Company Profile
LifeScan, Inc. is a US-based manufacturer of blood glucose monitoring systems and diabetes management solutions, headquartered in Malvern, Pennsylvania, USA. Founded in 1981, the company was acquired by Johnson ＆ Johnson in 1986 and subsequently by private equity firm Platinum Equity in October 2018 for approximately USD 2.1 billion. In July 2025, LifeScan filed for Chapter 11 restructuring and successfully emerged in December 2025 with its debt reduced by over 75 percent, now operating as a privately held company under majority ownership of its existing lender group. The company serves more than 20 million consumers across over 70 countries with approximately 2,000 employees worldwide.
Core Products & Technologies
Blood Glucose Monitoring Systems
• OneTouch Verio Flex: Bluetooth-connected blood glucose meter with ColorSure technology for instant feedback on glucose trends
• OneTouch Verio Reflect: Smart meter featuring Blood Sugar Mentor messages to help users understand their readings
• OneTouch Ultra: Iconic meter platform delivering fast, accurate results with a compact form factor
• OneTouch Delica Plus: Precision lancing device designed for comfortable blood sampling
Continuous Glucose Monitoring
• OneTouch Vita CGM System: Continuous glucose monitoring sensor and transmitter developed in partnership with i-SENS, planned for launch in Germany, Ireland, Portugal, and Belgium by early 2027
Digital Health & Data Management
• OneTouch Reveal Mobile App: iOS and Android-compatible diabetes management app syncing glucose data for pattern sharing with caregivers
• OneTouch Reveal Web Portal: Cloud-based platform for healthcare providers to review patient glucose trends and generate reports
• LifeScan Diabetes Institute: Educational resource offering accredited continuing education for healthcare professionals
Hospital & Point-of-Care Systems
• OneTouch Verio Pro: Professional-grade glucose monitoring system for clinical settings and hospital point-of-care testing
• OneTouch Test Strips & Control Solutions: Proprietary electrochemical test strips ensuring accuracy across the product ecosystem
Market Position & Certifications
LifeScan holds a leading position in the global blood glucose monitoring market, competing with Abbott Diabetes Care (FreeStyle) and Roche Diagnostics (Accu-Chek). Key strengths include:
• 40+ years of diabetes care innovation heritage
• OneTouch Brand Equity: One of the most recognized and physician-recommended glucose monitoring brands worldwide
• Regulatory compliance: FDA cleared, CE marked, and compliant with ISO 15197 accuracy standards
• Manufacturing footprint: Blood glucose test strip production facility in Inverness, Scotland, employing over 1,100 people
• Digital ecosystem growth: Double-digit growth in connected-device user base and mobile app engagement
Corporate Timeline
1981 — Founded in the United States, pioneering user-friendly blood glucose monitoring technology
1986 — Acquired by Johnson & Johnson, becoming the cornerstone of J&J's diabetes device division
1987 — Launched the OneTouch meter-and-strip system, revolutionizing at-home glucose testing with automated timing
2001 — Introduced OneTouch Ultra, delivering five-second test results and enhanced memory storage
2014 — Released OneTouch Verio Sync, adding wireless smartphone connectivity for data sharing
2018 — Divested by J&J and acquired by Platinum Equity for USD 2.1 billion, emerging as an independent private company
2023 — Published real-world evidence in Diabetes Therapy showing clinically significant glycemic control improvements via connected meter-and-app ecosystems
2025 — Filed for Chapter 11 in July to reduce debt; successfully emerged in December with over 75 percent debt elimination
2026 — February: Announced transformational CGM partnership with i-SENS to launch OneTouch Vita; May: Jonathan Salkin appointed CEO
Target Markets & Applications
• Home Diabetes Management: Personal blood glucose meters, test strips, and lancing devices for Type 1 and Type 2 diabetes patients
• Hospital Point-of-Care: Professional glucose testing systems for emergency departments, ICUs, and bedside monitoring
• Digital Health Integration: Connected meter-to-app ecosystems enabling remote patient monitoring and caregiver collaboration
• Healthcare Professional Education: Accredited training programs through the LifeScan Diabetes Institute for nurses, pharmacists, and diabetes educators
Contact Information
Global Headquarters
Address: 75 Valley Stream Parkway, Suite 201, Malvern, PA 19355, USA
Tel: +1-800-227-8862
Website: lifescan.com / onetouch.com
Ownership Structure
LifeScan, Inc. operates as a privately held company. Following the
December 2025 Chapter 11 emergence, the company is majority-owned by its existing lender group.
Former Owner: Platinum Equity (2018–2025)
CEO: Jonathan Salkin (appointed May 2026)
Investor Relations: Not applicable — privately held company with no publicly traded stock.
